Search

High-resolution structures of human PLPP3 reveal lipid binding and active-site organization

Yunhai Li , Cheng-Cen Guo , James Jiqi Wang , Qingning Yuan , Jiuyin Xu , Zhenyu Cao , Xiaoqi Guo , Wen Hu , Yichao Lin , Heng Zhang , Yong Li , H. Eric Xu , Canrong Wu

Vita ››

Vita > Correspondence > DOI: 10.15302/vita.2026.11.0092
Vita Open AccessPublished:

High-resolution structures of human PLPP3 reveal lipid binding and active-site organization

Author information +
History +
Vita () Cite this article
PDF (5818KB)

登录浏览全文

4963

注册一个新账户 忘记密码

Dear Editor,
Bioactive lipid phosphates signal from within membranes, yet terminating these signals poses a common challenge for lipid enzymes: a hydrophobic substrate must reach a polar catalytic site at the membrane−water interface. Lysophosphatidic acid (LPA), sphingosine-1-phosphate, and phosphatidic acid are three major classes of bioactive lipids, and they regulate migration, inflammation, endothelial integrity, and vascular remodeling. Phospholipid phosphatases (PLPPs) limit these signals by hydrolyzing their phosphate headgroups1-4. Mammalian PLPP1, PLPP2, and PLPP3 share a six-transmembrane fold and conserved catalytic motifs, but PLPP3 is biologically nonredundant. Its loss disrupts vascular development and is linked to coronary artery disease. PLPP3 supports endothelial and vascular homeostasis5-11. PLPP3 also partitions into cholesterol- and sphingolipid-enriched membrane domains distinct from those occupied by PLPP112,13. These observations suggest that isoform specificity may be encoded not in the conserved active site, but in the surrounding membrane-facing architecture. We therefore asked how PLPP3 couples bilayer-confined substrate entry to hydrolysis and whether sterols regulate this process.
To address both questions, we determined cryo-electron microscopy (cryo-EM) structures of full-length human PLPP3 in three states: a cholesterol hemisuccinate (CHS)-bound apo state at 1.98 Å, a CHS-containing LPA-incubated state at 2.28 Å, and an apo state prepared without added CHS at 1.97 Å (Fig. 1; Supplementary Figs. S1–S4 and Table S1). Independent C1 and C4 refinements converged on the same compact tetramer under these detergent conditions (Supplementary Figs. S2, S3). Beyond the conserved PLPP fold3,4,14, the two sub-2-Å reconstructions resolve side-chain rotamers, individual solvent peaks, and ordered lipid- and sterol-associated densities with near-atomic clarity (Fig. 1b; Supplementary Fig. S4). Direct protein contacts establish the tetrameric geometry, while reproducible lipid-like densities fill membrane-facing grooves between protomers (Fig. 1c). Interface-associated substitutions reduce activity (Supplementary Fig. S5), supporting the functional importance of these regions without establishing a requirement for tetramerization.
The structures reveal an extensively hydrated catalytic chamber. Hundreds of ordered water molecules populate the extracellular/luminal loops, internal cavities, and membrane-proximal regions (Supplementary Fig. S1a–c). Discrete solvent densities surround the conserved polar and basic residues and phosphate-binding region (Fig. 1a–c), showing that water is an integral component of the active-site architecture. This hydrated chamber provides the polar environment needed for phosphotransfer while remaining directly connected to the bilayer (Fig. 1c). An ordered water molecule adjacent to H251 is a candidate for hydrolysis of the phosphohistidine intermediate in the conserved PAP2 mechanism, in which H251 acts as the nucleophile and H199 supports acid-base catalysis3.
The structures also trace a route from the membrane to the catalytic chamber. PLPP3 converts LPA or phosphatidic acid (PA) to monoacylglycerol (MAG) or diacylglycerol (DAG) respectively, with release of inorganic phosphate (Pi) (Fig. 1a). The product-compatible state links that access route to the chemistry that it feeds. Pi sits in the catalytic chamber within a polar and basic network of K148, R155, S197, R245, and H251, with H199 positioned for acid-base catalysis and E190 located just outside this network (Fig. 1c, e). Alanine substitution of any of these residues except E190 reduces phosphate release to the level of the assay control; E190A retains partial activity, indicating that E190 contributes to active-site organization but is not strictly required for catalysis (Fig. 1f). The close alignment of these side chains across all three states is consistent with lipid accommodation and phosphotransfer within a largely preorganized scaffold, without requiring a large-scale conformational transition (Fig. 1d, e).
The three structures resolve sterol at three distinct positions, which differ in their occupancy across states (Fig. 1c). Two lie within the membrane-access pocket: the first sterol, CHS-1, sits at the entrance from the bilayer, and the second sterol, CHS-2, is located in an adjacent recess, with its sterol scaffold directed toward the catalytic chamber; the hemisuccinate moiety is not well resolved (Fig. 1c). In the LPA-incubated structure both sterol densities are absent, a density modeled as MAG occupies the CHS-1 channel, and no ligand is modeled in the CHS-2 recess (Fig. 1c). Proximity to the active site is therefore not sufficient for stable sterol occupancy. The third position behaves differently. A lateral pocket, distinct from the access route, is sterol-occupied in all three preparations: CHS-3 is resolved there in both CHS-containing structures, and an overlapping CLR occupies the same site in the structure prepared without added CHS (Fig. 1g, h). This persistent site is distinct from the substrate access route and is a candidate for sterol-dependent regulation; its contribution to the CHS effect remains untested.
The overlapping positions of CHS-1 and MAG within the substrate-access route prompted us to investigate whether CHS affects PLPP3 activity. Using protein purified without added CHS and matched LMNG vehicle controls, we found that 200 μM CHS unexpectedly enhanced, rather than suppressed, phosphate release: LPA and PA hydrolysis increased by approximately 42% and 35%, respectively (n = 3 independent measurements; Fig. 1i; Supplementary Fig. S6; absolute wild-type (WT) specific activities are reported in the Supplementary Information). This consistent enhancement across two substrates demonstrates a reproducible biochemical effect of CHS under the tested detergent conditions. One possible explanation is that exchangeable sterol occupancy in the access region and favorable lateral interactions that affect local packing have different functional consequences. Their net effect could enhance activity despite transient restriction of substrate access, although the contribution of each site remains unproven.
These results support a structural framework for PLPP3 function. PLPP3 assembles into a tetramer associated with ordered lipid under these conditions, and accommodates lipids in a shared sterol/acylglycerol pocket. Hydrolysis occurs in a preorganized, water-rich chamber. Its phosphate-binding region and membrane-facing cavity can accommodate a shared headgroup and different acyl-chain configurations, providing a basis for LPA/PA promiscuity2-4. The catalytic residues resolved here are essentially superimposable on those of PLPP1 and PLPP23,4, whereas the lipid-facing surfaces and their bound ligands differ markedly. These differences may contribute to lipid recognition. The less conserved interface may offer sites for isoform-selective binding. The genetic association of the PLPP3 locus with coronary artery disease provides a rationale for defining its lipid-binding and catalytic architecture, which may inform future investigations of its vascular functions6,7. The high-resolution structures define lipid-binding and hydration features, while CHS-associated activity changes provide a basis for further mechanistic investigation.

DATA AVAILABILITY

The cryo-EM density maps and atomic coordinates of human PLPP3 have been deposited in the Electron Microscopy Data Bank (EMDB) and the Protein Data Bank (PDB), respectively: CHS-bound apo PLPP3 (EMD-85000; PDB 47ZH), CHS-containing LPA-incubated PLPP3 (EMD-84998; PDB 47ZF), and apo PLPP3 prepared without added CHS (EMD-84999; PDB 47ZG). These accession codes are listed in Supplementary Table S1. Supporting biochemical data are presented in the main text and Supplementary Information. The software used for data processing and analysis is described in the Supplementary Information.

[1]

Chun, J., Hla, T., Lynch, K.R., Spiegel, S. & Moolenaar, W.H. Pharmacol. Rev. 62, 579–587 (2010).

[2]

Sigal, Y.J., McDermott, M.I. & Morris, A.J. Biochem. J. 387, 281–293 (2005).

[3]

Yang, M., Sun, C.P., He, Y.L. & Qian, H.W. Nat. Chem. Biol. 22, 793–801 (2026).

[4]

Wang, W.Y., Xu, Y., Guo, P.L., Han, H. & Han, L. Structure 34, 955–962.e3 (2026).

[5]

Escalante-Alcalde, D. et al. Development 130, 4623–4637 (2003).

[6]

Schunkert, H. et al. Nat. Genet. 43, 333–338 (2011).

[7]

Reschen, M.E. et al. PLoS Genet. 11, e1005061 (2015).

[8]

Wu, C.Q. et al. Circ. Res. 117, e41–e53 (2015).

[9]

Touat-Hamici, Z. et al. Cardiovasc. Res. 112, 702–713 (2016).

[10]

Chabowski, D.S. et al. J. Physiol. 601, 469–481 (2023).

[11]

Mueller, P.A. et al. Arterioscler. Thromb. Vasc. Biol. 39, 2261–2272 (2019).

[12]

Jia, Y.J., Kai, M., Wada, I., Sakane, F. & Kanoh, H. FEBS Lett. 552, 240–246 (2003).

[13]

Kai, M. et al. J. Biochem. 140, 677–686 (2006).

[14]

Wu, Y.J. et al. Nat. Commun. 17, 8823 (2026).

RIGHTS & PERMISSIONS

The Author(s) 2026. Published by Higher Education Press. This is an Open Access article distributed under the terms of the CC BY license (https://creativecommons.org/licenses/by/4.0/).

Cite this article

Download citation ▾
Li, Y. et al.  High-resolution structures of human PLPP3 reveal lipid binding and active-site organization  Vita https://doi.org/10.15302/vita.2026.11.0092 ()
AI Summary AI Mindmap
PDF (5818KB)

Supplementary Files

Supplementary Materials

Sections
Figures
References

913

Accesses

0

Citation

Detail

Recommended

AI思维导图

/

〈 〉